Title | Blood virosphere in febrile Tanzanian children. | ||
Author | Cordey, Samuel; Laubscher, Florian; Hartley, Mary-Anne; Junier, Thomas; Keitel, Kristina; Docquier, Mylene; Guex, Nicolas; Iseli, Christian; Vieille, Gael; Le Mercier, Philippe; Gleizes, Anne; Samaka, Josephine; Mlaganile, Tarsis; Kagoro, Frank; Masimba, John; Said, Zamzam; Temba, Hosiana; Elbanna, Gasser H; Tapparel, Caroline; Zanella, Marie-Celine; Xenarios, Ioannis; Fellay, Jacques; D'Acremont, Valerie; Kaiser, Laurent | ||
Journal | Emerg Microbes Infect | Publication Year/Month | 2021-Dec |
PMID | 33929935 | PMCID | PMC8171259 |
Affiliation + expend | 1.Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland. |
Viral infections are the leading cause of childhood acute febrile illnesses motivating consultation in sub-Saharan Africa. The majority of causal viruses are never identified in low-resource clinical settings as such testing is either not part of routine screening or available diagnostic tools have limited ability to detect new/unexpected viral variants. An in-depth exploration of the blood virome is therefore necessary to clarify the potential viral origin of fever in children. Metagenomic next-generation sequencing is a powerful tool for such broad investigations, allowing the detection of RNA and DNA viral genomes. Here, we describe the blood virome of 816 febrile children (<5 years) presenting at outpatient departments in Dar es Salaam over one-year. We show that half of the patients (394/816) had at least one detected virus recognized as causes of human infection/disease (13.8% enteroviruses (enterovirus A, B, C, and rhinovirus A and C), 12% rotaviruses, 11% human herpesvirus type 6). Additionally, we report the detection of a large number of viruses (related to arthropod, vertebrate or mammalian viral species) not yet known to cause human infection/disease, highlighting those who should be on the radar, deserve specific attention in the febrile paediatric population and, more broadly, for surveillance of emerging pathogens.Trial registration: ClinicalTrials.gov identifier: NCT02225769.